<DOC>
	<DOCNO>NCT01408277</DOCNO>
	<brief_summary>Subjects enrol study either use Santyl daily follow standard care procedures 6 week diabetic foot wound . After 6 week treatment , subject continue follow-up phase additional 6 week . Study doctor look wound office week ( 12 week ) see wound heal . Depending number factor office visit , study doctor may also use procedure call sharp debridement remove dead skin wound . This study test hypothesis daily treatment diabetic foot wound Santyl result rapid healing , healthy wound , few require sharp debridement study period diabetic foot wound treat way .</brief_summary>
	<brief_title>Using Santyl Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>INCLUSION CRITERIA Provide write informed consent , consist reading , signing , date informed consent document Investigator , subInvestigator designate study staff member explain study procedure , risk , contact information . Subjects 18 year age old . Subjects may either sex race skin type provide skin color , opinion Investigator , interfere study assessment . A target ulcer 0.5 cm2 10 cm2 inclusive ( measure Screening Visit ) duration ≥ 30 day ( documented patient 's history patient report onset ) require sharp surgical debridement . Adequate arterial blood flow evidence ankle brachial index ( ABI ) &gt; 0.7 ≤ 1.1 . If ABI great 1.1 , toe pressure &gt; 40 mmHg OR TcPO2 ≥ 40 mmHg must present . Either toe pressure TcPO2 also acceptable standalone measurement , obtain , must meet respective cutoff . Alternatively , Doppler waveform consistent adequate flow region foot target ulcer ( biphasic triphasic waveform ) acceptable . A target ulcer infect base clinical assessment . Willing able make require study visit . Able follow instruction perform dress change home caregiver perform dressing change accord protocol . Willing use appropriate offloading device whenever necessary keep weight foot ulcer . History diabetes mellitus ( Type 1 2 ) require insulin oral hypoglycemic medication control blood glucose level . CBC blood chemistry value follow : Serum albumin ≥ 2.0 g/dL Prealbumin level ≥ 15 mg/dL Alkaline phosphatase ≤ 500 U/L Alanine aminotransferase ( ALT ) ≤ 200 U/L Aspartate aminotransferase ( AST ) ≤ 175 U/L Serum total bilirubin ≤ 3.0 mg/dL Serum BUN &lt; 75 mg/dL Serum creatinine ≤ 4.5 mg/dL HbA1c ≤ 12 % Hemoglobin ( Hgb ) &gt; 8.0 g/dL WBC &gt; 2.0 x 109/L Absolute neutrophil count &gt; 1.0 x 109/L Platelet count &gt; 50 x 109/L EXCLUSION CRITERIA Contraindications hypersensitivity use study medication component . Target ulcer require debridement . Uncontrolled bleed disorder . Cellulitis target wound , lymphangitic streaking , deep tissue abscess , gangrene , infection muscle , tendon , joint bone . Infection systemic toxicity metabolic instability ( e.g. , fever , chill , tachycardia , hypotension , confusion , vomit , leukocytosis , acidosis , severe hyperglycemia , azotemia ) . Any follow : Target ulcer tunnel Target ulcer require hyperbaric negative pressure therapy per investigator 's medical judgment Target ulcer heel offload Target ulcer Charcot deformity offload NOTE : A heel ulcer ulcer Charcot exclude unless effective offload possible . Current , ongoing osteomyelitis target foot determine medical history . Participation another investigational clinical study within thirty ( 30 ) day Screening Visit . A target ulcer involve underlie tissue ( i.e. , fat , fascia , tendon , muscle , bone ) . A target ulcer nonneuropathic foot ( neuropathic define inability perceive 10 gram pressure use SemmesWeinstein 5.07 equivalent monofilament periwound area ) . NOTE : Monofilament test result must document . Diagnosis chronic granulomatous disease , leukocyte adhesion defect , severe neutropenia . Current treatment ( time Screening Visit ) following : Systemic corticosteroid Immunosuppressive agent Chemotherapeutic agent Antiviral agent Plateletderived growth factor ( e.g. , Regranex ) Living skin equivalent ( e.g. , Apligraf ) Dermal substitute ( e.g. , Dermagraft , Integra , etc . ) Systemic antibiotic therapy topical antibiotic treatment target ulcer Radiation therapy target low extremity within 30 day prior screen The Medical Monitor and/or Investigator may declare subject ineligible valid medical reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Diabetic Foot Ulcers</keyword>
	<keyword>Diabetic Foot Wounds</keyword>
</DOC>